Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis

• Päätekijät: Ryan Geffin MD (Tekijä), Shazia Raheem PharmD (Tekijä), Lavannya M. Pandit MD, MS (Tekijä), Andrew S. Hunter PharmD (Tekijä), Michael W. Holliday MD, PhD (Tekijä), Aditya V. Rao (Tekijä), Maulin K. Shah MD (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2023-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

End-stage kidney disease (ESKD) has been shown to be correlated with an increased risk of COVID-19 infection and mortality. Remdesivir is an effective non-EUA U.S. Food and Drug Administration (FDA)-approved antiviral agent for the treatment of COVID-19 in hospitalized adult and pediatric patients,...